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MObjective: Since 2007, the Japanese Red Cross Blood Center has provided prestorage leukocyte-reduced red
blood cell concentrates in which the leukocytes were reduced soon after collection. We have established a min-
iaturized bypass system (140 mL) to reduce the perioperative inflammatory responses. This study was designed to
reveal the effectiveness of leukocyte-reduced red blood cell concentrate transfusion on perioperative inflamma-
tory responses in pediatric cardiac surgery.
Methods: Between May 2006 and June 2008, 50 consecutive patients weighing less than 5 kg who underwent
a surgical procedure with red blood cell concentrate transfusion using a miniaturized bypass system were re-
viewed retrospectively. Twenty-five patients before 2007 received stored red blood cell concentrate in which leu-
kocytes were reduced with a filter just before transfusion (group A). After 2007, 25 patients received the
prestorage leukocyte-reduced red blood cell concentrate transfusion (group B). The postoperative peak C-reactive
protein level, peak white blood cell count, peak neutrophil count, percentage body weight gain, inotrope score,
plasma lactate concentration, postoperative mechanical ventilation time, and length of intensive care unit stay
were compared as the perioperative inflammatory response and morbidity for both groups.
Results: There were no significant differences in peak white blood cell count, peak neutrophil count, percentage
body weight gain, and inotrope score between the groups. The peak C-reactive protein level in group A was sig-
nificantly greater than that in group B (6.7 4.7 vs 4.2 3.6 mg/dL, P<.05). The lactate concentration at 12 and
24 hours after surgical intervention in group A was significantly greater than that in group B (3.1  2.5 vs 1.9 
1.1 mmol/L [P<.05] and 2.2 0.2 vs 1.4 0.2 mmol/L [P<.05], respectively). The postoperative mechanical
ventilation time and intensive care unit stay in group A were significantly greater than those in group B (5.9 7.4
vs 2.1  2.0 days [P< .05] and 9.8  7.9 vs 5.0  2.1 days [P< 0.05], respectively). Multivariate analyses
showed that the leukocyte-reduced red blood cell concentrate transfusion reduced the peak C-reactive protein
level (in milligrams per deciliter; coefficient,2.95; 95% confidence interval [CI],4.66 to0.93; P¼ .003), post-
operative mechanical ventilation time (in days; coefficient,3.41; 95% CI,6.07 to0.74; P ¼ .013), and inten-
sive care unit stay (in days; coefficient,4.51; 95% CI,7.37 to1.64; P ¼ .003).
Conclusions: Our study revealed that in neonates and small infants, compared with transfusions with stored
red blood cell concentrate, transfusion of leukocyte-reduced red blood cell concentrates was associated with
reduced perioperative inflammatory responses and improved clinical outcomes. (J Thorac Cardiovasc Surg
2010;139:1561-7)It is well known that cardiopulmonary bypass (CPB) acti-
vates perioperative systemic inflammatory responses be-
cause the contact of blood components with CPB circuits
is one of the major causes of inflammation.1,2 In neonates
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The Journal of Thoracic and Carately much larger than in adults relative to the patients’ size
and blood volume. The hyperinflammatory state is an impor-
tant contributor to post-CPB organ dysfunction in neonates
and small infants.1,2
Because of the small circulating volume of blood, extreme
hemodilution occurs when a large CPB circuit is used. In that
event a homologous blood transfusion is required before and
during CPB in neonates and small infants. Since 2005, we
have applied a miniaturized (minimum, 140 mL) and biocom-
patible poly (2-methoxyethylacrylate) (PMEA)–coated bypass
system3 to reduce the perioperative inflammatory responses
and avoid homologous blood transfusion.4,5 We can prime
the bypass circuits without blood products for patients weigh-
ing more than 5 kg. For neonates and small infants weighing
less than 5 kg, homologous blood transfusion is still needed.diovascular Surgery c Volume 139, Number 6 1561
Abbreviations and Acronyms
%BWG ¼ percentage body weight gain
CPB ¼ cardiopulmonary bypass
CRP ¼ C-reactive protein
FFP ¼ fresh frozen plasma
ICU ¼ intensive care unit
ICUS ¼ intensive care unit stay
p-CRP ¼ peak C-reactive protein
PMEA ¼ poly (2-methoxyethylacrylate)
PMN ¼ polymorphonuclear neutrophil
PMVT ¼ postoperative mechanical
ventilation time
p-NC ¼ peak neutrophil count
p-WBC ¼ peak white blood cell count
RACHS-1 ¼ Risk Adjustment in Congenital
Heart Surgery
RBC ¼ red blood cell
RCC-LR ¼ leukocyte-reduced red blood cell
concentrates
WBC ¼ white blood cell count
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MHowever, whole-blood transfusion generates an inflam-
matory response and might contribute to organ dysfunction
after CPB.6 The circuit priming with fresh whole blood is as-
sociated with an increased length of stay in the intensive care
unit (ICU) and increased perioperative fluid overload.6 These
results suggested that neutrophils remaining in the fresh
whole blood can be activated and release elastase, resulting
in the perioperative inflammatory response seen after CPB.
During storage of red blood cell (RBC) concentrates, the
leukocytes release cytokines and enhance polymorphonu-
clear neutrophil (PMN) priming.7,8 These cytokines prime
polymorphonuclear leukocytes for cytotoxicity, prompting
the release of lytic enzymes during bypass. The prestorage
leukocyte removal reduced the cytokine levels in stored
RBCs.9 Since 2007, the Japanese Red Cross Blood Center
has provided prestorage leukocyte-reduced RBC concen-
trates (RCC-LR) in which leukocytes were reduced before
storage (Figure 1).
This studywas designed to reveal the effectiveness ofRCC-
LR transfusion for perioperative inflammatory responses in
neonates and small infants weighing less than 5 kg.MATERIALS AND METHODS
Between May 2006 and June 2008, 50 consecutive patients weighing
less than 5 kg who underwent a surgical procedure with an RBC transfusion
using a miniaturized bypass system in the Kitasato University Hospital were
reviewed retrospectively.
All the patients received an RBC transfusion in the priming of CPB. The
mean age and body weight were 3.2  2.9 months (range, 2 days–12
months), and 3.9  0.9 kg (range, 2.3–4.9 kg), respectively. There were
25 male and 25 female patients.1562 The Journal of Thoracic and Cardiovascular SurThe Japanese Red Cross Society discontinued providing conventional
stored RBCs after January 2007. Twenty-five patients before 2007 received
stored RBCs in which leukocyteswere reducedwith a filter just before trans-
fusion (group A). After 2007, 25 patients received the RCC-LR transfusion
(group B, Figure 1). The type of procedures and Risk Adjustment in Con-
genital Heart Surgery 1 (RACHS-1) scores10 in both groups are shown in
Table 1.
Miniaturized Biocompatible Bypass System
Our miniaturized CPB system was reported previously.4 A low-prime
oxygenator and reservoir (Priming volume, 40 mL; Baby RX; Terumo,
Inc, Tokyo, Japan), arterial filters (15 mL; Filtia; JMS, Inc, Hiroshima,
Japan), and a smaller and shortened extracorporeal circuit were needed to
achieve a low-priming-volume CPB system. To shorten the circuit, the
CPB roller pump was placed close enough to the operative field to minimize
the tubing length. Our CPB system consisted of a distant roller-pump head,
a remote-controlled unit, and a sterilized sheet. The distant roller pump and
remote-controlled unit (TONOKURA Compo III; Tonokura Medical, Inc,
Tokyo, Japan) allowmaximal proximity to the operative field. The sterilized
sheet (50 mm 3 100 mm; SteriSheet; Tonokura Medical, Inc), which is
made of polyvinyl chloride, acts as a protective barrier between the first as-
sistant and the CPB unit.4 The arterial, venous, and suction tubes are at-
tached to the sheet and then covered by an unwoven polypropylene sheet.
The tubes were 3/16 inch in diameter at the pump heads, and the rest of
the tubes were 5/32 inch in diameter. By using this system, the total length
of the circuit was reduced to about 280 cm, and its priming volume was re-
duced to 65 mL. The minimum priming volume of this system is currently
140 mL, with 15 mL of the reservoir level. The biocompatible surface coat-
ing can reduce the inflammatory response and improve the outcome of
cardiac surgery. PMEA is one of the potential coating materials, and
PMEA-coated circuits have already been reported to suppress the inflamma-
tory response in clinical settings.3 We have used the PMEA-coated bypass
system successfully for all such patients since January 2005.
CPB Techniques
Wemonitored mixed venous oxygen saturation and regional cerebral ox-
ygenation using near-infrared spectroscopy (INVOS 5100; Somanetics, Inc,
Troy, Mich) during CPB and maintained these values at greater than 70%
and 50%, respectively. The plasma lactate level (in millimoles per liter)
was also monitored during bypass. Blood gas management was performed
with the pH-stat strategy. High-flow (200 mL$kg1$min1) normal-to-mild
hypothermic (32C) CPB was used. CPB with regional cerebral perfusion
through the right innominate artery at a moderate hypothermic temperature
(25C) was selected for patients undergoing aortic arch repair, such as the
Norwood procedure and interruption repair. Deep hypothermic cardiac ar-
rest was not used in any patients. Crystalloid cardioplegic solution (10
mL/kg) was administered every 20minutes. After termination of the bypass,
modified ultrafiltration was performed with a polymethylmethacrylate he-
mofilter in all patients. Modified ultrafiltration was started with an ultrafil-
tration rate of 20 mL$kg1$min1 for 10 minutes. The heparinization was
neutralized by protamine sulfate until the activated coagulation time had
normalized. The remaining blood in the CPB circuit was returned to the
patient within the operative day. Methylprednisolone sodium succinate
(30 mg/kg; Solu-Medrol; Pharmacia & Upjohn Co, New York, NY) was
routinely given to all patients before bypass. Aprotinin was not used in
this study.
Study Protocol
The patients’ body weight gain was estimated by measuring the preop-
erative and postoperative (immediately after the operation) body weight
in all patients. The body weight gain was expressed as percentage body
weight gain (%BWG) in this study. Blood examinations, including mea-
surement of C-reactive protein (CRP) levels,11 white blood cell countsgery c June 2010
FIGURE 1. Prestorage leukocyte-reduced red blood cells.
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M(WBCs), and neutrophil counts (NCs), were performed at 12, 24, 48, and 72
hours postoperatively for each patient. The plasma lactate concentrate was
measured at 0, 12, 24, and 36 hours postoperatively for each patient. An ino-
tropic support score was calculated at 24 hours after arrival in the ICU by
means of the following formula, using drug dosages expressed as micro-
grams per kilogram per minute: DopamineþDobutamineþ (Epinephrine
3 100)þ (Milrinone 3 10).6 The inotrope score was obtained at 0, 6, 12,
18, 24, and 36 hours postoperatively for each patient.
The %BWG and postoperative peak C-reactive protein (p-CRP) level,
peak white blood cell count (p-WBC), peak neutrophil count (p-NC),
plasma lactate concentrate, inotrope score, postoperative mechanical venti-
lation time (PMVT), and length of intensive care unit stay (ICUS) were
compared as indications of the perioperative inflammatory responses and
morbidity between groups. Data on sex; body weight; CPB time; procedure
time; the amount of RBCs, fresh frozen plasma (FFP), and platelets trans-
fused; and the complexity of the procedure (RACHS-1 scores) were col-
lected from all patients.
Statistical Analyses
First, descriptive statistics of the subjects were obtained. Second, univar-
iate analyses were performed between groups A and B. The p-CRP level,
p-WBC, p-NC, %BWG, plasma lactate concentration, inotrope score,
PMVT, and ICUS with the other variables were examined. Subsequently,
multivariate analysis was performed. For continuous variables (body
weight, age, CPB time, procedure time, blood transfusion, %BWG,The Journal of Thoracic and Carp-CRP level, p-WBC, p-NC, plasma lactate concentration, and inotrope
score), Spearman’s rank correlation coefficients are shown with signifi-
cance. The RACHS-1 score was first treated as a continuous variable and
then also as an ordinal (categorical) variable. The stepwise multiple regres-
sion analysis was used to obtain a set of independent/explanatory variables
that best predicted the dependent variables (p-CRP level, p-WBC, p-NC,
%BWG, PMVT, and ICUS). Explanatory variables were entered and re-
moved in a stepwise fashion at a P value of .05 to produce the most accurate
predictive model. When the explanatory variables in the final model were
significantly correlated with the dependent variables, regression analysis
was further pursued, dropping those correlated variables one by one to
check the robustness of the final model to colinearity. All dependent and in-
dependent/explanatory variables are listed in Table 2.
Institutional Review Board Approval
The institutional review board approved the use of the miniaturized by-
pass system, and all the data collection was performed according to the
guidelines of this board.RESULTS
Univariate Analyses
There were no operative deaths. The clinical characteris-
tics and surgical data in both groups are shown in Table 3.diovascular Surgery c Volume 139, Number 6 1563
TABLE 3. Clinical characteristics and surgical data
Group A
(n ¼ 25)
Group B
(n ¼ 25) P value
Age (mo) 3.3  2.9 3.1  2.9 .84
Body weight (kg) 3.8  0.9 3.9  0.8 .55
RACHS-1 score 3.3  1.5 3.2  1.3 .92
Procedure time (min) 289  70 279  79 .64
Perfusion time (min) 147  52 134  59 .41
RBC transfusion (mL) 128  38 129  49 .94
FFP transfusion (mL) 20  35 34  44 .2
Platelet transfusion (mL) 24  39 29  43 .65
RACHS-1, Risk Adjustment in Congenital Heart Surgery; RBC, red blood cell; FFP,
fresh frozen plasma.
TABLE 1. Procedure and RACHS-1 score
RACHS-1
score Procedure
No. of patients
in group A
No. of patients
in group B
2 VSD 4 5
BCPS 2 2
TOF 2 1
3 AVSD 2 2
BTSþPAP 1 3
DORV 3 1
ASO 1 2
Aortoplasty 2 0
CoA/VSD 2 0
RV–PA conduit 0 1
4 Rastelli 1 1
TAPVC 0 2
ASOþVSD 0 1
6 Norwood 4 3
DKS 1 1
Mean 3.3  1.5 3.2  1.3
RACHS-1, Risk Adjustment in Congenital Heart Surgery 1; VSD, ventricular septal de-
fect closure; BCPS, bidirectional cavopulmonary shunt; TOF, tetralogy of Fallot re-
pair; AVSD, atrioventricular septal defect repair; BTS þ PAP, Blalock–Taussig
shunt and pulmonary artery plasty; DORV, double-outlet right ventricle; ASO, arterial
switch operation; CoA, coarctation of aorta repair; RV–PA, right ventricle–pulmonary
artery; TAPVC, total anomalous pulmonary venous connection repair; DKS, Damus–
Kaye–Stansel anastomosis.
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MThere were 12 (48%) patients who received FFP, platelets,
or both in group A and 13 (52%) in group B. There were no
significant differences in age, body weight, RACHS-1 score,
procedure time, perfusion time, or the amount of blood
transfusion (RBCs, FFP, and platelets) between the groups.
The time course of CRP level is shown in Figure 2. The
CRP levels at 24 and 48 hours after surgical intervention in
group A were significantly greater than those in group B
(P ¼ .042 and P ¼ .046, respectively). The p-CRP level in
group A was significantly greater than that in group B
(P ¼ .042, Table 4). There were no significant differences
in p-WBC, p-NC, and %BWG values between the groups
(Table 4). The time course of the plasma lactate level is
shown in Figure 3. The lactate concentrates at 12 and 24TABLE 2. Dependent and independent variables in multivariate
analyses
Dependent variables Independent variables
Peak CRP, Age
Peak WBC, Sex
Peak NC Body weight
%BWG, RACHS-1 score
PMVT Perfusion time
ICUS Procedure time
RCC-LR transfusion
Amount of blood transfusion
(FFP, platelets)
CRP, C-reactive protein;WBC, white blood cell count; NC, neutrophil count;%BWG,
percentage of body weight gain; RACHS-1, Risk Adjustment in Congenital Heart Sur-
gery; PMVT, postoperative mechanical ventilation time; RCC-LR, leukocyte-reduced
red blood cell concentrates; FFP, fresh frozen plasma.
1564 The Journal of Thoracic and Cardiovascular Surhours after surgical intervention in group A were signifi-
cantly greater than those in group B (P ¼ .040 and
P ¼ .021, respectively).
There were no significant differences in inotrope scores
between the groups. The PMVT and ICUS in group A
were significantly greater than those in group B (P ¼ .014
and P ¼ .005, respectively; Table 4).
Multiple Regression Analyses
The multiple regression analysis results are shown in
Table 5. The patients’ body weight, RCC-LR transfusion,
and procedure time affected p-CRP levels. A 1-unit change
in body weight (in kilograms) and procedure time (in min-
utes) increased the p-CRP level by 2.13 and 0.022 mg/dL,
respectively, and the use of RCC-LR reduced the p-CRP
level by 2.95 mg/dL. The amount of RBC transfusion, in-
cluding both conventional stored RBCs and RCC-LR, af-
fected the p-NC and p-WBC. A 1-unit change in RBC
transfusion volume (in milliliters) increased the p-WBC
(31000/mm3) and p-NC (31000/mm3) by the amount indi-
cated by their corresponding coefficient values. The combi-
nation of procedure time, RCC-LR transfusion, and patients’
age affected PMVT the most. Finally, the combination of
RCC-LR transfusion and procedure time was the only sig-
nificant variable associated with ICUS.FIGURE 2. Time course of C-reactive protein (CRP). RCC-LR, Leuko-
cyte-reduced red blood cells. *P< .05.
gery c June 2010
TABLE 4. Univariate analyses
Group A
(n ¼ 25)
Group B
(n ¼ 25) P value
p-CRP (mg/dL) 6.7  4.7 4.2  3.6 .042
p-WBC (31000/mm3) 17.1  5.9 18.2  7.4 .55
p-NC (31000/mm3) 13.5  5.1 13.6  7.2 .93
%BWG 3.1  2.6 2.1  2.0 .15
Lactate at 12 h ICU (mmol/L) 3.1  2.5 1.9  1.1 .04
Lactate at 24 h ICU (mmol/L) 2.2  0.2 1.4  0.2 .021
PMVT (d) 5.9  7.4 2.1  2.0 .014
ICUS (d) 9.8  7.9 5.0  2.1 .005
p-CRP, Peak C-reactive protein; p-WBC, peak white blood cell count; p-NC, peak neu-
trophil count;%BWG, percentage body weight gain; ICU, intensive care unit; PMVT,
postoperative mechanical ventilation time; ICUS, length of intensive care unit stay.
TABLE 5. Multiple regression analyses
Coefficient
95% Confidence
interval
P
value
p-CRP (mg/dL)
Body weight (kg) 2.13 1.03 to 3.22 .001
RCC-LR transfusion 2.95 4.96 to0.93 .003
Procedure time (min) 0.022 0.08 to 0.36 .005
p-NC (31000/mm3)
RBC transfusion (mL) 0.073 0.038 to 0.11 .0001
p-WBC (31000/mm3)
RBC transfusion (mL) 0.079 0.041 to 0.12 .0001
PMVT (d)
RCC-LR transfusion 3.41 6.07 to0.74 .013
Procedure time (min) 0.034 0.012 to 0.056 .003
Age (mo) 0.53 0.99 to0.07 .025
ICUS (d)
RCC-LR transfusion 4.51 7.37 to1.64 .003
Procedure time (min) 0.035 0.09 to 0.061 .01
p-CRP, Peak C-reactive protein; RCC-LR, leukocyte-reduced red blood cell concen-
trate; p-NC, peak neutrophil count; RBC, red blood cell; p-WBC, peak white blood
cell count; PMVT, postoperative mechanical ventilation time; ICUS, length of inten-
sive care unit stay.
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MDISCUSSION
Blood products are needed in cardiac surgery for small
children to avoid hemodilution. Efforts have been made to
minimize the unnecessary use of homologous blood in the
pediatric population.12,13 The miniaturized CPB system
might allow transfusion-free cardiac surgery for small in-
fants and children.13 In our institution we have developed
a priming volume CPB system with a minimal volume of
140 mL. Using this system, we can prime the CPB circuit
without blood products for patients weighing more than
5 kg. In our previous report, of 70 patients weighing between
4 kg and 7 kg, 45 (64%) underwent cardiac surgery without
blood transfusion.4 As reported in our previous study, the
limiting factors of bloodless cardiac surgery are not the pre-
operative hematocrit value or the complexity of the proce-
dure but the CPB time and the patient’s body weight.4 For
patients weighing less than 5 kg requiring a longer CPB
time, blood transfusion is still needed, even with the minia-
turized bypass system.
The contact of blood components with CPB circuits is one
of the major causes of inflammation.1,2 The reduction of
priming volume can improve postoperative hemodynam-
ics.14 We reported that the miniaturized biocompatible cir-
cuits reduced the perioperative inflammatory response,FIGURE 3. Time course of plasma lactate concentrate. RCC-LR, Leuko-
cyte-reduced red blood cells; CPB, cardiopulmonary bypass. *P< .05.
The Journal of Thoracic and Carresulting in reduced postoperative systemic edema and
PMVT in neonates and small infants.5
Blood products, especiallywhen stored, amplify the inflam-
matory response by delaying PMN apoptosis and enhancing
PMNpriming.7,8,14 It is well known that the prestorage leuko-
cyte removal reduced the plasma cytokine levels.9,15 Leuko-
cyte reduction soon after blood collection is better than
bedside filtration to improve the quality of the blood products.
Many blood centers have begun to implement prestorage leu-
kocyte reduction in Europe.16 Since 2007, the Japanese Red
Cross Blood Center has been providing prestorage RCC-LR
in which the leukocytes were reduced before storage, with
the current filters reducing the number of leukocytes present
in blood by 4 logs (104), a value below which it is believed
that alloimmunization or suppression does not occur.17 Before
2007, we used the storedRBC reduced leukocytes, using radi-
ation and a filter just before transfusion. The current study re-
vealed the effectiveness of prestorageRCC-LR transfusion for
perioperative inflammatory response. Both univariate and
multivariate analyses showed that use of RCC-LR decreased
postoperative p-CRP levels, postoperative ventilation times,
and ICUSs. There were no significant differences in inotrope
scores between these groups; however, the plasma lactate con-
centrates at 12and 24hours after surgical intervention ingroup
A were significantly greater than those in group B. RCC-LR
transfusion improved the postoperative hemodynamics asso-
ciated with reduced ventilation time and ICUS.
In these patient groups FFP and platelets were also trans-
fused along with RBCs. In Japan, for FFP and platelets, pre-
storage leukocyte reduction has been performed since 2004.
The amount of these products transfused did not affect the
postoperative inflammatory response, as shown in multi-
variate analyses.diovascular Surgery c Volume 139, Number 6 1565
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MMou and colleagues6 reported that circuit priming with
fresh whole blood is associated with an increased ICUS
and increased perioperative fluid overload compared with
priming with RBCs. However, they did not use leukode-
pleted whole blood, and leukocytes in the whole blood might
have caused the postoperative inflammatory responses.
Therefore we have routinely used RBCs for the circuit prim-
ing. Recently, Gruenwald and associates18 reported that re-
constituted fresh whole blood improves clinical outcomes
compared with stored component blood therapy for neonates
undergoing CPB in a randomized controlled trial. In Canada
prestorage leukocyte depletion is a standard for blood com-
ponent preparation. Therefore in both the reconstituted fresh
whole blood group and the conventional stored component
blood therapy group, leukocyte reduction was performed.
In the study reported by Mou and colleagues,6 the use of
blood that had not been leukodepleted could offset gains
made by using fresh whole blood. Our study found an asso-
ciation of leukocyte depletion with some improved out-
comes. The reconstituted fresh whole blood was derived
from a single donor. A reduction in the number of donors
might reduce the risk of transmission of infection and the in-
flammatory responses caused by CPB. On the other hand,
the use of reconstituted fresh whole blood is not practical
in many countries. Gruenwald and associates18 mentioned
that an alternative strategy might include the use of reconsti-
tuted fresh components from multiple donors in which leu-
kocyte depletion should be completed. This might
replicate the effect of reconstituted fresh whole blood with-
out the challenge of obtaining single-donor products.
In the present study there were no significant differences
in %BWG between groups A and B, as discovered in the
univariate analyses. In the multivariate analyses the use of
RCC-LR and any other independent variables did not affect
the %BWG. By using our miniaturized biocompatible by-
pass system, postoperative inflammatory responses could
be considerably suppressed.5 In fact, the data for%BWG it-
self, which represents perioperative fluid overload, in both
groups were relatively insignificant (3.1% in group A vs
2.1% in group B).
To achieve less invasive cardiac surgery for neonates and
small infants, the following key steps should be considered.
Use the miniaturized biocompatible bypass system to mini-
mize blood transfusion, including the volume of blood prod-
ucts and the number of donors. Transfuse the blood
components leukocyte reduced, when needed.
Study Limitations
During the past 3 years of this study period, the perfusion
strategy and postoperative care were unchanged. The pres-
ent study is a retrospective study, and the number of patients
was small (n ¼ 50). Nevertheless, stepwise multiple regres-
sion analyses suggested that RCC-LR transfusion is associ-
ated with some improvements.1566 The Journal of Thoracic and Cardiovascular SurThe Japanese Red Cross Blood Center has discontinued
providing stored RBCs without leukocyte reduction since
January 2007. Therefore it was impossible to perform the
prospective randomized study in our country.
Because this is an observational study, it cannot rule out
the possibility that some confounding factors exist that
were not examined here. In the future, our results should
be confirmed by means of randomized controlled trials. Fur-
thermore, several results warrant cautious interpretation be-
cause of the small number of study subjects and the
exploratory nature of the study. Adjustment of significance
levels for multiple comparisons/testing could require some
of our results to be accepted with reservation. We intend
to reanalyze the data when larger numbers of subjects be-
come available. The heterogeneity of patients can then be
handled more meaningfully in the analyses.CONCLUSIONS
Our study revealed that in neonates and small infants,
compared with transfusions with stored RBCs, RCC-LR
transfusion was associated with reduced perioperative in-
flammatory responses and improved clinical outcomes.References
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